Skip to main content
Mega Genomics Limited logo

Mega Genomics Limited — Investor Relations & Filings

Ticker · 6667 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 317 across all filing types
Latest filing 2025-02-20 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 6667

About Mega Genomics Limited

https://www.megagenomics.cn

Mega Genomics Limited operates as a genetic testing platform company focused on providing consumer genetic testing and cancer screening services. The core business involves delivering comprehensive genetic analysis solutions to the consumer market. Key product offerings include advanced sequencing packages such as Personal Whole Genome Sequencing, which analyzes over 700,000 genetic loci to assess disease risk and provide pharmacogenomic recommendations. Additionally, the company offers Adult and Children's Whole Exome Sequencing packages, which analyze over 180,000 key exome regions to evaluate risks for high-risk diseases, hereditary cancers, and complex genetic disorders, alongside personalized guidance on drug efficacy, nutrition, and fitness.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (FF305) detailing changes in issued shares and treasury shares, with extensive schedules of share repurchases, prices, repurchase mandates and on‐market sales of treasury shares. It is not an earnings, management or annual report but a regulatory disclosure of the company’s own share transactions. This matches the definition for Transaction in Own Shares (share repurchase/issuance).
2025-02-20 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) filed on the Hong Kong Stock Exchange detailing changes in issued shares, treasury shares, and a schedule of share repurchases by Mega Genomics Limited, including number of shares repurchased, dates, prices, and confirmations. This is a detailed report of the company’s own share transactions (buybacks and treasury share movements), matching the ‘Transaction in Own Shares’ category.
2025-02-19 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a FF305 “Next Day Disclosure Return” filed under the Hong Kong Exchange rules, detailing the company’s share repurchase activity, treasury share changes, and on‐market sales of treasury shares. It provides a full record of the issuer buying back its own shares, including dates, quantities, prices, and confirmations under the listing rules. This matches the definition of “Transaction in Own Shares” (POS).
2025-02-18 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (FF305) required by the Hong Kong Stock Exchange rules, detailing changes in issued shares and treasury shares and providing a detailed report on share repurchases made on the market. This is a regulatory disclosure of the company buying back its own shares, which corresponds to the "Transaction in Own Shares" filing category.
2025-02-17 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Exchange "Next Day Disclosure Return" (Form FF305) detailing changes in issued shares and treasury shares, including a detailed repurchase report (Section II) and on‐market sale of treasury shares (Section III). It is clearly a report of the company’s share buybacks (transaction in own shares) under Main Board Rule 10.06 and GEM Rule 13.13, matching the definition of “Transaction in Own Shares” (POS).
2025-02-14 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (FF305) under Hong Kong Listing Rules, detailing changes in issued shares, treasury shares, and specifically multiple on‐market share repurchases and repurchase mandates. It is not a report publication announcement, AGM material, or earnings release. It is a detailed share buyback/treasury share transaction report by the issuer. Therefore, it falls under Transaction in Own Shares (Code: POS).
2025-02-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.